Gout is a type of inflammatory arthritis. It occurs when your blood has a buildup of uric acid. This acid causes crystals to ...

The company is one of a handful developing a more “selective” URAT1 inhibitor, an approach that’s seen as a way to improve upon existing therapies.

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Crystalys Therapeutics launched on Tuesday armed with ...

Gout is the most common type of inflammatory arthritis. Eating foods like red meat, alcohol, and shellfish make the symptoms ...

Beyond joint problems, excess uric acid can also lead to kidney stones. Doctors stress early diagnosis and some changes can ...

Crystalys Therapeutics has emerged from its cocoon with $205 million first-round financing and a potential treatment for gout ...

Kid Rock Makes Quite A Claim About Trump And Black Communities — And Experts Would Like A Word LeSean McCoy Shares Honest ...

Crystalys Therapeutics said on Tuesday it has emerged from stealth mode with a funding round of $205 million to help finance global late-stage trials of its lead drug as a treatment for gout.

Gout was associated with a 30% higher risk for chronic opioid exposure based on US Veteran's Health Administration data. Patients with gout in the United States are at greater risk for chronic opioid ...

Noah Lyles believes Australian sprint sensation Gout Gout is a better sprinter than the 100m Olympic champion was at the same age. Gout missed out on a place in the 200m final at the World Athletics ...

Anti-inflammatory colchicine will be tested as a possible COVID-19 treatment in one of the world's biggest trials, the study website posted on Friday, the latest effort to repurpose existing medicines ...